Virtus LifeSci Biotech Products ETF (BBP) Holdings $61.00 -1.37 (-2.20%) Closing price 04:10 PM EasternExtended Trading$61.02 +0.02 (+0.03%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Top 50 BBP HoldingsRankCompanyCurrent PriceWeightShares Held1CRSPCRISPR Therapeutics$52.73-6.5%2.11%10,7652INSMInsmed$102.87+1.0%2.08%4,5873BBIOBridgeBio Pharma$46.97-1.5%2.03%11,2084IONSIonis Pharmaceuticals$42.00-1.3%2.02%12,4765ACADACADIA Pharmaceuticals$22.01+0.5%1.98%20,4416EXELExelixis$44.06-3.3%1.98%10,6377KNSAKiniksa Pharmaceuticals International$28.09-2.5%1.98%16,0268ALNYAlnylam Pharmaceuticals$311.12-1.5%1.97%1,4599ASNDAscendis Pharma A/S$174.75-0.1%1.97%2,60010MIRMMirum Pharmaceuticals$51.98-2.4%1.96%9,066 Get the Latest News and Ratings for BBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virtus LifeSci Biotech Products ETF and its competitors with MarketBeat's FREE daily newsletter. 11LGNDLigand Pharmaceuticals$124.30-2.1%1.92%3,88312NBIXNeurocrine Biosciences$131.24-2.9%1.92%3,55513ROIVRoivant Sciences$11.36-2.3%1.92%38,74414UTHRUnited Therapeutics$293.24-1.5%1.91%1,55315TARSTarsus Pharmaceuticals$40.58-2.3%1.90%10,85216TBPHTheravance Biopharma$11.53+0.5%1.90%41,88417RYTMRhythm Pharmaceuticals$89.36+0.2%1.89%7,05218BNTXBioNTech$110.65-0.3%1.88%4,23619KRYSKrystal Biotech$147.73-1.8%1.88%3,16720REGNRegeneron Pharmaceuticals$547.96-4.0%1.88%85221ARDXArdelyx$4.50-2.4%1.87%119,46122TGTXTG Therapeutics$37.96-2.5%1.87%11,89223INCYIncyte$68.25-2.5%1.86%6,42024PTCTPTC Therapeutics$47.75-3.5%1.86%8,71725AGIOAgios Pharmaceuticals$39.19-0.1%1.85%12,88126DAWNDay One Biopharmaceuticals$6.57-5.2%1.85%66,42727HALOHalozyme Therapeutics$56.60-1.8%1.85%8,14828TVTXTravere Therapeutics$16.38-3.1%1.85%29,74529VRTXVertex Pharmaceuticals$464.20-1.7%1.84%96630AXSMAxsome Therapeutics$110.12-2.0%1.83%4,18331HRMYHarmony Biosciences$34.84+0.4%1.83%13,33332AUPHAurinia Pharmaceuticals$8.99-0.6%1.82%53,99733BCRXBioCryst Pharmaceuticals$8.72-2.7%1.82%42,73034MDGLMadrigal Pharmaceuticals$311.14-2.7%1.82%1,49535BMRNBioMarin Pharmaceutical$56.62-2.8%1.81%7,75836GILDGilead Sciences$109.06-2.7%1.81%3,96637PHATPhathom Pharmaceuticals$8.54-5.7%1.81%44,30638BIIBBiogen$127.50-4.2%1.80%3,35939DVAXDynavax Technologies$10.44-2.8%1.80%42,73040MRNAModerna$31.58-3.9%1.79%16,248A grave, grave error. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you.41RAREUltragenyx Pharmaceutical$27.20-6.9%1.79%11,31142ONCBeOne Medicines$269.70+7.0%1.78%1,60743FOLDAmicus Therapeutics$5.91-5.3%1.77%72,02544AMGNAmgen$292.51-1.5%1.75%1,49545APLSApellis Pharmaceuticals$19.35-2.8%1.75%23,07346GERNGeron$1.26-6.0%1.74%284,86847LEGNLegend Biotech$39.59+0.4%1.71%11,72248NVAXNovavax$6.88-1.3%1.69%62,15349IMCRImmunocore$35.15-0.4%1.67%12,47250IBRXImmunityBio$2.74-5.5%1.65%139,309 Geographic ExposureUnited States88.9%Switzerland2.4%Canada2.0%United Kingdom1.8%Bermuda1.8%Currency ExposureUSD100.1%Sector ExposureHealth Care95.1%Consumer Discretionary1.8%Industry ExposureBiotechnology89.8%Pharmaceuticals5.3%Distributors1.8%SubIndustry ExposureBiotechnology86.8%Pharmaceuticals7.1%Coupon Exposure0-21.2% Related Companies and Tools Related Companies Goldman Sachs Future Health Care Equity ETF Holdings Harbor Health Care ETF Holdings Horizon Kinetics Medical ETF Holdings First Trust Nasdaq Pharmaceuticals ETF Holdings Virtus LifeSci Biotech Clinical Trials ETF Holdings Invesco Nasdaq Biotechnology ETF Holdings T. Rowe Price Health Care ETF Holdings Direxion Daily Pharmaceutical & Medical Bull 3X Shares Holdings JPMorgan Healthcare Leaders ETF Holdings Global X HealthTech ETF Holdings This page (NYSEARCA:BBP) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
